For: | Jeong JY, Sohn JH, Baek YH, Cho YK, Kim Y, Kim H. New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial. World J Gastroenterol 2017; 23(32): 5977-5985 [PMID: 28932090 DOI: 10.3748/wjg.v23.i32.5977] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i32/5977.htm |
Number | Citing Articles |
1 |
Zuanji Liang, Xianwen Chen, Junnan Shi, Hao Hu, Yan Xue, Carolina Oi Lam Ung. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-020-00422-x
|
2 |
Marcin Kosmalski, Rafał Frankowski, Kacper Deska, Monika Różycka-Kosmalska, Tadeusz Pietras. Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds. Nutrients 2023; 15(13): 2838 doi: 10.3390/nu15132838
|
3 |
Anne-Laure Agrinier, Arianne Morissette, Laurence Daoust, Théo Gignac, Julie Marois, Thibault V. Varin, Geneviève Pilon, Éric Larose, Claudia Gagnon, Yves Desjardins, Fernando F. Anhê, Anne-Marie Carreau, Marie-Claude Vohl, André Marette. Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial. Cell Reports Medicine 2024; 5(8): 101682 doi: 10.1016/j.xcrm.2024.101682
|
4 |
Yuan Ma, Kewei Sun, Jianzhong Cao, Xiaowu Qin, Jiaoling Shi, Huiying Li, Jun Zhang, Tao Zhang. Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease. Medicine 2021; 100(51): e28083 doi: 10.1097/MD.0000000000028083
|
5 |
Myung-Ho Kim, Subin Ahn, Nayeon Hur, Seung-Yun Oh, Chang-Gue Son. The additive effect of herbal medicines on lifestyle modification in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1362391
|
6 |
Dulmini Wathsala Rathnayake, Piumika Sooriyaarachchi, Madunil Anuk Niriella, Dileepa Ediriweera, Jennifer Perera. Herbal treatments for non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Advances in Integrative Medicine 2024; doi: 10.1016/j.aimed.2024.08.016
|
7 |
Ma Ai Thanda Han, Osama Altayar, Shadi Hamdeh, Varun Takyar, Yaron Rotman, Ohad Etzion, Eric Lefebvre, Rifaat Safadi, Vlad Ratziu, Larry J. Prokop, Mohammad Hassan Murad, Mazen Noureddin. Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2019; 17(4): 616 doi: 10.1016/j.cgh.2018.06.011
|
8 |
Tess Armstrong, Holden H. Wu. Quantitative Magnetic Resonance Imaging. Advances in Magnetic Resonance Technology and Applications 2020; 1: 695 doi: 10.1016/B978-0-12-817057-1.00029-9
|
9 |
Na-yeon Kim, Mi-jung Yoon, Hong-sik Choi, Seung-mo Kim, Sang-chan Kim, Kyung-soon Kim. A Review of Research Trends in Traditional Korean Medicine for Nonalcoholic Fatty Liver Disease. The Journal of Internal Korean Medicine 2022; 43(4): 680 doi: 10.22246/jikm.2022.43.4.680
|
10 |
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(7) doi: 10.1002/14651858.CD013157.pub2
|